April MIMS update

We look at some of the recent changes to the medicines landscape, with new products as well as changes to indications New products Belzutifan (Welireg) is an inhibitor of hypoxia‑inducible factor 2 alpha (HIF‑2α). HIF‑2α is a transcription factor that plays a role in oxygen sensing by regulating genes that promote adaptation to hypoxia. Under